Clinical Trials Logo

Filter by:
NCT ID: NCT03659565 Terminated - Clinical trials for Cardiovascular Diseases

Increasing Caregiver and Patient Engagement Through PHR Use

Start date: April 23, 2019
Phase: N/A
Study type: Interventional

Informal caregivers play an integral role in managing complex, chronic disease patients providing services equivalent to an estimated economic value of $470 billion. The inclusion of informal caregivers in the healthcare team can improve care coordination and make health care safer by reducing potential medical errors caused by miscommunication. the investigators reason that a properly designed PHR with a simplified user interface and easy access to relevant content can improve the management of chronic diseases and better integrate caregivers and patients into the healthcare team.

NCT ID: NCT03658629 Terminated - Influenza, Human Clinical Trials

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Start date: September 24, 2018
Phase: Phase 2
Study type: Interventional

A Phase 2 trial to confirm the dose and formulation, demonstrate adjuvant effect, and evaluate the safety and tolerability of a single intramuscular injection of Quad-NIV with or without Matrix-M1 adjuvant in healthy adults ≥ 65 years of age. A total of approximately 1375 subjects were to be randomized to seven treatment groups to receive Quad-NIV or an active comparator.

NCT ID: NCT03658135 Terminated - Clinical trials for Nonfluent Aphasia, Progressive

BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

TauBasket
Start date: September 12, 2018
Phase: Phase 1
Study type: Interventional

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel Cohort Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Intravenously Infused BIIB092 in Patients with Four Different Primary Tauopathy Syndromes

NCT ID: NCT03658109 Terminated - Gynecologic Cancer Clinical Trials

Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone

Start date: September 24, 2019
Phase: Early Phase 1
Study type: Interventional

This study may provide evidence for whether or not systemic lidocaine infusion offers significant advantage over truncal regional blocks in gynecology oncology surgery patients in terms of post-operative analgesia, recovery, and safety profile. Further, it may show whether there is any increased efficacy of adding truncal regional block or systemic lidocaine versus intrathecal opioid administration alone.

NCT ID: NCT03657251 Terminated - Multiple Myeloma Clinical Trials

MMRF CureCloud Research Initiative

Start date: July 14, 2020
Phase:
Study type: Observational [Patient Registry]

The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.

NCT ID: NCT03657108 Terminated - Prostate Cancer Clinical Trials

CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation

Start date: March 27, 2018
Phase: N/A
Study type: Interventional

A phase I single-arm open label dose escalation study to evaluate the maximum tolerated dose (MTD) and safety of Civasheet® with radical prostatectomy (RP) and adjuvant external beam radiation therapy (EBRT) in a 3+3 dose escalation design among participants with high risk prostate cancer (PCa).

NCT ID: NCT03657095 Terminated - Clinical trials for Pulmonary Arterial Hypertension

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

BEAT OLE
Start date: December 10, 2018
Phase: Phase 3
Study type: Interventional

This is a multi-center, open-label study for eligible participants who were actively participating in the BPS-314d-MR-PAH-302 double-blind study (NCT01908699) at the time the study was concluded. This open-label extension (OLE) study will evaluate the safety, tolerability, and efficacy of long-term treatment with esuberaprost sodium tablets (Beraprost Sodium 314d Modified Release tablets).

NCT ID: NCT03656913 Terminated - Nephrolithiasis Clinical Trials

Validation of Low Dose CT for Diagnosis of Urolithiasis

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

The investigators have developed an extremely low dose renal computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of a single view abdominal radiograph. The investigators plan to test this exam in patients with known or suspected urolithiasis undergoing clinically indicated CT.

NCT ID: NCT03656692 Terminated - Uveitis, Posterior Clinical Trials

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

Start date: October 5, 2018
Phase: Phase 4
Study type: Interventional

The main reason for this study is to see if Acthar Gel can reduce inflammation in the uvea. Also, safety information when using it for this purpose will be collected.

NCT ID: NCT03656679 Terminated - Pain, Postoperative Clinical Trials

Paravertebral Versus Pectoralis Block for Post Mastectomy Pain

Start date: October 18, 2018
Phase: N/A
Study type: Interventional

Post-mastectomy pain affects more than half of patients undergoing the procedure and can last for years. It has been well established that development of chronic pain is related to experienced pain in the perioperative period. This study therefore aims to assess if both acute and chronic post-operative mastectomy pain can be better managed by a novel regional anesthesia nerve block known as the pectoralis block (PECs). The PECs block is easier for patients to position for placement, has less risk of harm to nearby structures, and less risk for systemic uptake of local anesthetic in comparison to the paravertebral block. The PECs block has a strong safety profile. Standard of care at University of Wisconsin (UW) hospital is to utilize regional anesthesia for post op pain management. While PVB is performed on a regular basis at UW per surgeon request, Surgeon can request for PECS block in patients where a PVB was contraindicated (ie. coagulation issues). PECS is in fact the standard of care at other hospitals. This study will assess outcomes in the post anesthetic care unit (PACU), post-operative day 1, 7 and 30.